Sartorius Stedim Biotech S.A Stock – Fundamental Analysis
Fundamental Data & Ratios (Balance sheet update: 3/9/2026)
| Balance Sheet | Total Assets | 8,017,400,000.00 | ROE | 51.02 % |
| Balance Sheet | Total Equity | 4,090,500,000.00 | ROA | 3.31 % |
| Cashflow | Capital Expenditures | -393,200,000.00 | P/FCF | 144.81 |
| Cashflow | Free Cash Flow | 145,400,000.00 | – | – |
| Cashflow | Operating Cash Flow | 538,600,000.00 | P/CF | 39.09 |
| Income | Earnings per Share (diluted) | 2.73 | Div. Yield | 0.32 % |
| Income | Net Income | 265,600,000.00 | P/E | 79.27 |
| Income | Shares Outstanding | 97,299,800.00 | P/B | 5.15 |
| Income | Total Revenue | 2,967,500,000.00 | P/S | 7.10 |
Ratios calculated on: 10/14/2026
Company Description
Sartorius Stedim Biotech S.A. produces and sells instruments and consumables for the biopharmaceutical industry worldwide. The company offers various products, such as cell lines; cell culture media; bioreactors; and a range of products for separation, purification, and concentration processes, as well as products and systems for storage and transportation of intermediate and finished biological products. It also provides cell cultivation, fermentation, filtration, purification, and fluid management services; single-use and reusable hollow-fiber membrane devices, as well as presterilized assemblies for cell and gene therapy applications; and cell harvesting and various other solutions for intensified bioprocesses. In addition, the company offers data analytics software for modeling and optimizing processes of biopharmaceutical development and production. It serves manufacturers of pharmaceuticals, foods, and chemicals, as well as research and development laboratories. The company was founded in 1870 and is headquartered in Aubagne, France. Sartorius Stedim Biotech S.A. is a subsidiary of Sartorius AG.
Additional comparison and history views are available after login.
Finanzoo GmbH assumes no liability for the accuracy of the information provided! All information is provided without guarantee. Sources: www.bundesanzeiger.de, www.sec.gov, www.sartorius.com
All metrics and scores are an automated evaluation and not investment advice or a recommendation to buy or sell. Finanzoo GmbH or its shareholders may themselves hold positions in the securities shown.
Learn more